ULK1 and lung carcinoma: CLDN1 was also shown to be a potent factor promoting lung cancer resistance to cisplatin, which was achieved by activating autophagy through the upregulation of Unc-51-like autophagy activating kinase 1 (ULK1) phosphorylation [29].